Epitranscriptomic profile of Lactobacillus agilis and its adaptation to growth on inulin.
Epitranscriptome
Inulin
Lactobacillus agilis
RNA modifications
Journal
BMC research notes
ISSN: 1756-0500
Titre abrégé: BMC Res Notes
Pays: England
ID NLM: 101462768
Informations de publication
Date de publication:
21 Apr 2021
21 Apr 2021
Historique:
received:
09
01
2021
accepted:
09
04
2021
entrez:
22
4
2021
pubmed:
23
4
2021
medline:
15
5
2021
Statut:
epublish
Résumé
Ribonucleic acids (RNA) are involved in many cellular functions. In general, RNA is made up by only four different ribonucleotides. The modifications of RNA (epitranscriptome) can greatly enhance the structural diversity of RNA, which in turn support some of the RNA functions. To determine whether the epitranscriptome of a specific probiotic is associated with its adaptation to the source of energy, Lactobacillus agilis (YZ050) was selected as a model and its epitranscriptome was profiled and compared by using mass spectrometry. The L. agilis epitranscriptome (minus rRNA modifications) consists of 17 different RNA modifications. By capturing the L. agilis cells during exponential growth, reproducible profiling was achieved. In a comparative study, the standard source of energy (glucose) in the medium was substituted by a prebiotic inulin, and a downward trend in the L. agilis epitranscriptome was detected. This marks the first report on a system-wide variation of a bacterial epitranscriptome that resulted from adapting to an alternative energy source. No correlation was found between the down-regulated RNA modifications and the expression level of corresponding writer genes. Whereas, the expression level of a specific exonuclease gene, RNase J1, was detected to be higher in cells grown on inulin.
Identifiants
pubmed: 33883017
doi: 10.1186/s13104-021-05563-2
pii: 10.1186/s13104-021-05563-2
pmc: PMC8058956
doi:
Substances chimiques
RNA
63231-63-0
Inulin
9005-80-5
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
154Références
Methods Enzymol. 2019;626:133-146
pubmed: 31606073
Trends Mol Med. 2018 Oct;24(10):886-903
pubmed: 30120023
Nucleic Acids Res. 2001 Nov 15;29(22):E112
pubmed: 11713332
FEBS Lett. 2019 Jul;593(13):1483-1493
pubmed: 31206634
Genome Biol. 2012 Oct 31;13(10):175
pubmed: 23113984
Eur J Clin Microbiol Infect Dis. 2020 Mar;39(3):403-413
pubmed: 31707507
J Bacteriol. 1997 Mar;179(6):1918-23
pubmed: 9068636
Toxics. 2019 Mar 25;7(1):
pubmed: 30934574
Biochemistry. 2005 Jun 28;44(25):9045-57
pubmed: 15966728
Nat Rev Mol Cell Biol. 2017 Mar;18(3):202-210
pubmed: 28144031
Appl Environ Microbiol. 2020 Dec 17;87(1):
pubmed: 33008824
Biochem J. 2019 Apr 26;476(8):1227-1245
pubmed: 31028151
Nucleic Acids Res. 2018 Jan 4;46(D1):D303-D307
pubmed: 29106616
Curr Opin Biotechnol. 2018 Feb;49:140-147
pubmed: 28866243
J Am Soc Mass Spectrom. 2019 Jun;30(6):987-1000
pubmed: 30847833
Mol Omics. 2020 Aug 1;16(4):305-315
pubmed: 32285055
Nat Rev Cancer. 2020 Jun;20(6):303-322
pubmed: 32300195
Nucleic Acids Res. 2016 Feb 18;44(3):e26
pubmed: 26438536
Curr Opin Biotechnol. 2018 Feb;49:217-223
pubmed: 29153882
Nat Rev Gastroenterol Hepatol. 2017 Aug;14(8):491-502
pubmed: 28611480
Nat Protoc. 2014 Apr;9(4):828-41
pubmed: 24625781
Anal Chem. 2019 Jan 2;91(1):743-756
pubmed: 30212618